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ABSTRACT 
Background : In tropical Africa, although chronic kidney disease (CKD) is common, 
there are few data about its’ prevalence among patients admitted to a general medical 
ward. Aim: We proposed to determine the prevalence of CKD among patients admitted 
to a general medical ward in Uganda. Methods : We conducted a cross sectional study 
consecutively enrolling adults admitted to the medical ward of Mbarara Regional 
Referral Hospital over three months. We collected socio-demographic and clinical data 
including presenting symptoms, history of diabetes, hypertension, and use of 
nephrotoxic medication. Consenting patients provided spot morning urine specimen for 
measurement of urine albumin and we also drew patients’ blood for measurement of 
markers of renal function, complete blood count, hepatitis B surface antigen, and HIV. 
We also performed renal sonography for all included patients.    We defined CKD as a 
glomerular filtration rate (eGFR) less than 60ml/min/1.73m².We used logistic regression 
to assess for factors associated with CKD. Results:  Of the 372 patients enrolled, 57 
(15.3%) had CKD. Body swelling (OR=2.79, 95% CI 1.53-5.07; p=0.001), active urine 
sediment (OR=3.13, 95% CI 1.64-6.41; p=0.016), microalbuminuria (OR=1.92, 95% CI 
1.07-3.43; p=0.028), history of hypertension (OR=3.65, 95% CI 1.69-7.90; p=0.001), and 
high blood pressure (OR=3.34, 95% CI 1.33-8.40; p=0.010) were independently 
associated with CKD. Conclusion:  Chronic kidney disease is common with 
hypertension as the etiology and associated with body swelling, active urine sediment 
and microalbuminuria among patients admitted to a general medical ward in 
southwestern Uganda. Screening for CKD of patients at risk should be prioritized in 
general medical wards. 
Key words: Chronic kidney disease, epidemiology, nephrotoxicity, poor resource 
setting, Uganda 
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The prevalence of impaired kidney 
function was estimated to range between 
10% and 20% of the adult population in 
most countries worldwide.[1] Data from 
United States suggest that for every 
patient with end stage renal disease 
(ESRD), there are more than 200 with 
overt CKD (stage 3 or 4) and almost 5000 
with covert disease (stage 1 or 2).[2] 
Analysis from the third national health 
and nutrition examination survey 
(NHANESIII) done on a representative 
sample of the United States (US) 
population showed that the prevalence 
rate of CKD was high.[2] Estimates from 
1999 to 2004 were higher (13.1%) than 
those in 1988 to 1994 (10.0%).[2] 
 
Studies from China suggest that between 
12.1%[3] and 13%[4] of the population 
have evidence of CKD and kidney 
damage markers. The profound impact of 
CKD on chronic diseases and 
cardiovascular morbidity makes it 
especially important in the context of 
global disease, specifically in developing 
countries that have a mounting incidence 
of CKD-associated risk factors.[1,5] 
 
In Africa, studies on CKD are scarce. 
Since little is known about CKD among 
people living with HIV/AIDS in Sub-
Saharan Africa, the prevalence was 
assessed in Burundi using the modified 
diet in renal disease (MDRD) formula and 
was found to be 45.7%.[6] According to 
the National Kidney Foundation (NKF), 
30.2% was classified as stage 1, 13.5% 
as stage 2 and 2% as stage 3 and none 
classified as stage 4 or 5.[6] In a cross-
sectional study done in Democratic 
Republic of Congo (DRC) among 
residents in 10 of the 35 health zones of 
Kinshasa, the prevalence of CKD 
according to kidney disease outcome 
quality initiative (K/DOQI) guidelines 
(2002) was 12.4% (95% CI, 11.0-15.1%) 
while 2% had stage 1, 2.4% had stage 2, 
7.8% had stage 3 and 0.2% had stage 
5.[7] In Uganda, the prevalence of CKD 
among patients attending the 
hypertension clinic of Mulago national 
referral hospital was found to be 17.2%.[8] 
 
In Mbarara, a prior study estimated the 
prevalence of renal disease among 
patients attending the HIV clinic of 
Mbarara University Teaching Hospital 
and found the prevalence of CKD to be 
around 12% among these patients.[9] 
Therefore, this study aimed to determine 
the prevalence of CKD among patients 
admitted to the medical ward of Mbarara 
Regional Referral Hospital (MRRH) and 




This was a cross sectional study 
conducted between over February and 
May 2013, on patients admitted to the 
medical ward of Mbarara Regional 
Referral Hospital (MRRH), Southwestern 
Uganda. At MRRH, patients with medical 
conditions are initially resuscitated in the 
emergency room where patients could 
stay overnight after admission before 
admission to the ward. Initial diagnoses 
are made by medical residents and then 
reviewed by faculty physicians. The 
facilities available at MRRH have been 
previously described.[10] 
 
Using the Kish and Leslie formula,[11] we 
enrolled 457 patients during our study 
which took place from 7th February 2013 
up to 16th May 2013.We consecutively 
included consenting adult patients aged 
18 years or more and excluded those 
with features of acute kidney injury such 
as vomiting, diarrhea, and/or low blood 
pressure.   
 
Per day, we enrolled a maximum of ten 
patients to allow ourselves time to 
perform kidney scans and to draw blood 
samples. The enrollment of patients and 
the scanning of the kidneys took place on 
afternoons of Sundays, Tuesdays and 
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We gave patients urine containers to 
collect about 15ml of early morning urine 
for measurement of albuminuria and 
urine microscopy for sediment.  Also, we 
drew approximately 8ml of blood for 
measurement of renal function test 
(serum creatinine& potassium), random 
blood sugar using handheld device (one 
touch), complete blood count, hepatitis B 
surface antigen, albumin and electrolytes 
(serum sodium & chloride) using machine 
HUMALYTE (Human 
GesellschaftfürBiochemica und 
Diagnostica, Gemany). All laboratory 
tests were performed on Mondays, 
Wednesdays and Fridays at the Mbarara 
University Clinical Research Laboratory, 
which participates in external quality 
assurance programs by the National 
Health Laboratory Service 
(Johannesburg, South Africa). 
 
An identification number was given to all 
patients who fulfilled the inclusion criteria. 
A standardized pre-tested questionnaire 
was then administered to them. We 
collected socio-demographic information: 
age and gender.  Risk assessment data 
included family history of kidney disease, 
history of recent nephrotoxic medication 
use (and the duration) such as non 
steroidal anti-inflammatory drugs 
(NSAIDs); history of diabetes, 
hypertension and HIV status. Data on the 
symptoms of kidney disease was 
obtained: history of dysuria, haematuria, 
and body swelling with its duration. 
 
Non-invasive measurements 
Weight and height are measured using 
the weighing scale machine Seca. Height 
was measured to the nearest 0.1 cm after 
removal of shoes. Weight was measured 
to the nearest kilogram after removal of 
shoes and heavy clothing. The BMI was 
calculated as weight in kilograms divided 
by the square of height in metres. Blood 
pressures were measured using a 
mercury sphygmomanometer with small 
(<21 cm) and normal (22–32 cm) cuff 
sizes on the left arm at the level of the 
heart while the patient was seated. When 
the blood pressure was found to be 
above 140/90mmHg, we repeated the 
measurement on three consecutive days 
during hospitalization to confirm 
hypertension.  
 
Kidney size measurements were 
performed using a standardized protocol 
by a single operator who completed a 
sonography training course at the 
department of Radiology, Makerere 
University college of health sciences. At 
the conclusion of the training, the 
operator performed paired measurements 
on volunteer participants daily to assure 
adequate image quality and calculate 
intra-observer reliability. All ultrasound 
measurements were performed with a 
Sonosite M-Turbo (Sonosite, Inc., Bothell, 
WA). We collected measurements of 
kidney sizes and echogenicity for all 
patients with supervision by a senior 
sonographer of the department of 
radiology at MRRH. 
 
Screening process 
The screening process consisted of 
estimating the GFR from serum 
creatinine using the MDRD formula and 
microalbuminuria from Urine Albumin 
Creatinine Ratio (UACR) formula. A urine 
dipstick was done to look for protein and 
blood; and, microscopy for cellular casts 
and red blood cells. Patients who were 
unable to give morning spot urine and 
those on whom we were unable to draw 
off blood were excluded.   
 
Urine albumin creatinine ratio 
We measured urine albumin using the 
chemical analyzer machine (Human 
Gesellschaft fur Biochemica und 
Diagnostica, Germany) by the 
Bromocresol-Green method (BCG-
method) which is a standard photometric 
colorimetric test for urine albumin. We 
determined urine creatinine concentration 
using the Jaffé rate reaction method 
which is a standard photometric 
colorimetric test for kinetic measurement 
of creatinine. Spot urine ACR ratio was 
calculated for all subjects by dividing the 
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Study procedures were reviewed and 
approved by the institutional review 
committee of Mbarara University of 
Science and Technology(MUST-IRC). All 
participants gave written informed 
consent. Patients found to have CKD 
stage 4 or 5 were referred to an in house 
renal physician for management. Those 
with CKD stage 1, 2 or 3, patients were 
prescribed angiotensin converting 
enzyme (ACE) inhibitor or angiotensin 
receptor blocker (ARB) and discharge 
through the renal clinic. 
 
Statistical analysis 
Data were summarized into tables using 
percentages, mean (standard deviation 
[SD], median and interquartile range 
[IQR]). Data were also represented 
graphically using flow-chart and 
histogram. We used unadjusted and 
multivariate logistic regression models to 
determine association between the some 
known risk factors and CKD. Results 
were considered statistically significant if 
a p value of less than 0.05 was obtained. 
All statistical analyses were conducted 





During the study period, 457 patients 
were screened. We excluded 59 patients 
(11 diarrhea and vomiting, 17 only 
diarrhea, 7 only vomiting, 24 declined 
consent). We analyzed data of 372 
patients after excluding 26 patients who 
did not complete (2 death, 14 no urine, 3 
blood sample hemolyzed, and 7 withdrew 
consent) (figure 1). 
 
When classified according to the National 
Kidney Foundation (NKF) definition of 
CKD, 213 had renal impairment which 
represents a prevalence of 57.3%. 71 
(19.1%) were found to have CKD stage 1; 
85 (22.8%) had CKD stage 2; 29 patients 
(7.8%) had CKD stage 3 of whom 19 
(5.1%) were in stage 3A and 10 (2.7%) in 
stage 3B. 11 patients (3.0%) were in 
stage 4 and 17 (4.6%) were in stage 5 or 
end stage renal disease (ESRD) (table 
2). 
 
Prevalence of chronic kidney disease  
Of the remaining 372 patients, 57 (15.3%, 
95% CI 11.6%-19.0%) had eGFR of less 
than 60ml/min/1.73m². When eGFR was 
tabulated against urine albumin creatinine 
ratio (UACR), 18 (4.8%) had CKD with 
microalbuminuria whereas 138 (37.1%) 
patients had normoalbuminuria and no 
CKD (table 2).  
 
Factors associated with chronic 
kidney disease 
In the univariate logistic analysis (table 
3), body swelling, history of hypertension, 
current high blood pressure, diabetes 
mellitus, microalbuminuria and active 
urine sediment were factors associated 
with CKD in patients admitted to our 
general medical ward during our study. 
However, in the multivariate model, body 
swelling, hypertension either history or 
current high blood pressure, active urine 
sediment and microalbuminuria remained 




Our study finding of a high prevalence of 
CKD among patients admitted to a 
general medical ward in a resource poor 
setting is similar to that documented in 
previous study[9] where CKD is a major 
public health problem. This prevalence is 
estimated using only 
eGFR<60ml/min/1.73m². If we exclude all 
patients without microalbuminuria having 
eGFR>60ml/min.1.73m², the prevalence 
goes up to 57.3%. This figure is higher 
than the one found by Johann among 
people living with HIV/AIDS in Burundi 
(45.7%).[7] This might be explained by the 
fact that our patients were not in good 
general condition. That is why we used 
only eGFR<60ml/min/1.73m² to estimate 
the prevalence as with this eGFR, 50% of 
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the function of the kidney is already 
affected.[12]  Our finding  is at the upper 
limit of the one seen in industrialized 
countries which in our setting implies a 
multifactorial effect resulting from an 
increase number of patients with 
 
hypertension, diabetes mellitus and 
HIV/AIDS.  In fact, this study was done in 
only three months and we diagnosed 30 
new patients with hypertension and 54 






















398 patients consented 
396 patients 




14 no urine 
3 blood sample hemolyzed 
7 withdrew consent 
2 died 
457 screened 11 diarrhea and vomiting 
17 only diarrhea 
7 only vomiting 
24 did not consent 
 
Figure 1: Flowchart of patients’ recruitment 
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Table 1: Baseline characteristics of study 
 
Baseline characteristics  
a. Socio -demographic  
Age (years); median (IQR) 
Gender; Male n (%) 
b. Clinical  
Dysuria; n (%) 
Haematuria; n (%) 
Body swelling; n (%) 
Duration of body swelling(months); median (IQR)
Family history of renal disease; n (%)
Known hypertensive; n (%) 
Known diabetic; n (%) 
Smoking; n (%) 
NSAIDs use; n (%) 
HIV positive; n (%) 
BMI≥30kg/m²; median (IQR) 
SBP/DBP (mmHg); median (IQR)
Diagnosed hypertensive; n (%) 
c. Laboratory  
eGFR (ml/min/1.73m²); median (IQR)
Fasting blood sugar (mmol/l); median (IQR)
Diagnosed diabetic; n (%) 
UACR 30-299mg/g; median (IQR)
UACR ≥ 300mg/g; mean±SD 
Active urine sediment; n (%) 
Electrolytes abnormalities; n (%)
HBsAg positivity; n (%) 
Hemoglobin (<11mg/dL); n (%) 
IQR= interquartile range; HBsAg: hepatitis B surface antigen; UACR: urine albumin to 
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Table 2: Distribution of patients according to estimated glomerular filtration rate (eGFR) 
and Urine albumin-creatinine ratio (UACR) 
 
UACR(mg/g)  
GFR(ml/min/1.73m²)   
< 30 >30 TOTAL 
< 60 39 18 57 
>60 138 177 315 
TOTAL 177 195 372 
 
 
Table 3: Factors associated with CKD among patients admitted on medical ward of 
MbararaRegional Referral Hospital 
 
Variables  CKD No CKD OR 95% CI P-value  
Age >65years 10 31 1.87 0.84-4.16 0.1201 
Female  32 149 1.43 0.81-2.52 0.2199 
Body swelling  37 120 3.01 1.65-5.49 0.0002 
FHRD 8 23 2.07 0.87-4.92 0.0910 
Known HTN  13 22 3.93 1.82-8.51 0.0002 
Known DM 2 19 0.57 0.13-2.51 0.4482 
NSAIDs use 11 79 0.71 0.35-1.45 0.3490 
HIV positive 15 111 0.59 0.31-1.14 0.1128 
BMI≥30kg/m² 33.16±1.55 32.57±0.57 1.38 0.35-5.54 0.6451 
Systolic BP( ≥140mmHg)  160.00±5.00 149.40±2.55 4.53 2.19-9.38 0.0000 
Diastolic BP( ≥90mmHg)  106.11±3.01 95±1.25 2.92 1.52-5.62 0.0008 
High FBG ( ≥7.0mmol/l)  10.47±1.41 10.76±0.84 2.09 1.11-3.94 0.0197 
Elevated BP  13 17 5.18 2.30-11.66 0.0000 
UACR 30-299 mg/g  69.04±5.75 63.05±3.58 2.19 1.19-4.04 0.0095 
Active urine sediment  51 63 6.09 2.81-13.40 0.0011 
Electrolytes abnormalities 49 158 1.90 1.60-6.43 0.0866 
HBsAg positivity 3 8 2.13 0.55-8.32 0.2647 
FHRD: family history of renal disease; FBS: fasting blood glucose; HBsAg: hepatitis B 
surface antigen, BMI: body mass index; OR: odds ratio; HBP: High blood pressure. 
 
Table 4: Independent factors of CKD among patients admitted on medical ward of 
Mbarara Regional Referral Hospital 
 
Variable  AjustedOdds Ratio 
(AOR) 
95% CI P value  
Body swelling 2.79 1.53-5.07 0.001 
Known hypertension 3.65 1.69-7.90 0.001 
Elevated blood pressure 3.34 1.33-8.40 0.010 
Active urine sediment 3.13 1.64-6.41 0.016 
Systolic BP (≥140mmHg) 3.28 1.36-7.92 0.008 
UACR 30-299mg/g 1.92 1.07-3.43 0.028 
HTN: hypertension; UACR: urine albumin to creatinine ratio. 
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Patients in stages 1; 2 and 3A (33.3%) 
need a proper follow up through renal 
clinic and be given drugs such ACEi or 
ARB to slow the progression to end stage 
renal disease (ESRD). The reason why 
patients present in ESRD is mainly 
because of lack of information and also 
the absence of screening of patients with 
known risk factors for CKD.  The figures 
of our study are higher than the ones 
found in HIV/AIDS patients in Burundi 
where 30.2% of the 45.7% were in stage 
1 of CKD and no patient was in stage 
either 4 or 5.[12] In Kinshasa, DRC, 12.2% 
were in stages 1 to 3 and only 0.2% of 
people enrolled was in stage 5.[7] 
 
High blood pressure has been recognized 
in many studies as a risk factor for 
CKD.[3, 7, 13, 14] In our study, patients 
known to have hypertension and those 
who were newly diagnosed to be 
hypertensive were all showing a 
correlation with CKD.  For those known 
hypertensive patients, the odds ratio was 
3.93 and for the newly diagnosed 
hypertensive patients, the odds ratio was 
5.18. This implies that hypertensive 
patients of our study are 4 to 5 times at 
risk of developing CKD. The odds of 
developing CKD are slightly lower in the 
group of patients known to have 
hypertension and are already on 
medications compared to those who are 
newly diagnosed with hypertension. Also, 
as hypertension is asymptomatic, many 
patients live with it undiagnosed and may 
present with complications such as renal 
involvement. 
 
Worldwide, diabetes mellitus is 
recognized as one of the leading causes 
of CKD. Studies done in USA,[2] China,[14] 
Nigeria[13] and DRC[7] found a correlation 
between diabetes mellitus and CKD 
respectively. Our patients with diabetes 
mellitus were 2 times likely to develop 
CKD than the non-diabetic patients. This 
is explained by the fact that these 
patients were diagnosed while having 
already complications, one of them being 
diabetic nephropathy. 
 
For patients who were known diabetic, 
we did not find any correlation between 
diabetes and CKD. It is possible that 
patients who are known to have diabetes 
had already been on medication and thus 
less likely to have CKD when compared 
to the newly diagnosed diabetics. 
Glycosylated haemoglobin (HbA1c) 
would have been ideal.  
 
Chronic use of NSAIDs had been 
associated with CKD as demonstrated by 
Johann in Burundi.[6] In our study, this 
correlation was not found partly because 
our patients denied the use of NSAIDs. 
For those who were using these drugs, 
they took them for less than a week. The 
odds ratio was 0.71. 
 
Human Immuno-deficiency Virus can lead 
to end stage renal disease (ESRD) 
through HIV associated nephropathy 
(HIVAN) especially in patients with low 
CD4 and not yet started on ARVs. This 
information was not recorded in our study 
as patients did not have their document 
with them to help us record the CD4 
count and know which regimen they were 
on. We did not perform any biopsy. 
However in South Africa, HIVAN was 
found in 86% of microalbuminuric 
patients who underwent renal biopsy.[15] 
 
CKD was associated with 
microalbuminuria. This is a known 
indicator for CKD. Hence, any patient 
with microalbuminuria should be 
screened for CKD and should have their 
UACR repeated after three months. A 
sub analysis done within patients with 
UACR ≥ 30mg/g revealed an association 
with high fasting blood sugar, 
hypertension, systolic and diastolic 
hypertension. After adjusting these 
factors, only high fasting blood sugar and 
systolic hypertension were independently 
associated with CKD. A recent study 
using data of an observational cohort 
showed that isolated microalbuminuria 
(that is, microalbuminuria in the absence 
of a cardiovascular disease (CVD) 
history, hypertension and diabetes) is 
associated with an increased risk for 
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incident cardiovascular events and 





The prevalence of CKD among adult 
patients admitted to a general medical 
ward of Mbarara Regional Referral 
Hospital was high (15.3%) and the 
majority of patients with CKD were in 
stages 1 and 2 using the NKF 
classification. Body swelling, history of 
hypertension, current high blood 
pressure, active urine sediment and 
microalbuminuria were independent 
factors related to the presence of CKD. 
These data are among the first to 
demonstrate a high prevalence of CKD 
among adult patients admitted to a 
general medical ward of a resource poor 
setting.  This signals an important need to 
further explore the early screening for 
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